Projects

PROGRESS - Policy and peer mentor intervention proGrams on cardiovascular disease at work Sites in 3 South Asian countries

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2015 - 2014

Project Lead

Dr. Denis Xavier, Dr. Tony Raj, Dr. Dhinagaran

Authors

Dr. Denis Xavier, Dr. Tony Raj, Dr. Dhinagaran

Project Status

completed

Project Type

Intramural